Jianquan Zhu

Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signals

Jianquan Zhu, Wen‐Zhao Zhong, Guochun Zhang et al. · Cancer Letters · 2008 · 125 citations

Medicine, Downstream Signals, Pathology +9

Checkpoint Kinase 1 Inhibition Enhances Cisplatin Cytotoxicity and Overcomes Cisplatin Resistance in SCLC by Promoting Mitotic Cell Death

Wei‐Hsun Hsu, Xiaoliang Zhao, Jianquan Zhu et al. · Journal of Thoracic Oncology · 2019 · 55 citations · Full text

Mitotic Cell Death, Oncology, Overcomes Cisplatin Resistance +12

Everolimus synergizes with gefitinib in non-small-cell lung cancer cell lines resistant to epidermal growth factor receptor tyrosine kinase inhibitors

Song Dong, Xu‐Chao Zhang, Hua Cheng et al. · Cancer Chemotherapy and Pharmacology · 2012 · 37 citations

Medicine, Receptor Tyrosine Kinase, Pharmacology +5

Succinate Dehydrogenase 5 (SDH5) Regulates Glycogen Synthase Kinase 3β-β-Catenin-mediated Lung Cancer Metastasis

Jun Liu, Liuwei Gao, Hua Zhang et al. · Journal of Biological Chemistry · 2013 · 35 citations · Full text

Succinate Dehydrogenase 5, Cell Signaling, Medicine +15

Structure basis of the caffeic acid O-methyltransferase from Ligusiticum chuanxiong to understand its selective mechanism

Simin Song, Anqi Chen, Jianquan Zhu et al. · International Journal of Biological Macromolecules · 2021 · 27 citations

Biosynthesis, Bioorganic Chemistry, Biotransformation +10